CHANG NANCY T — SEC Form 4 filings
SEC reporting owner CIK 1135041. 10 Form 4 filings on record with FilingPulse; latest filed 2026-08-05.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-06-18 to 2026-08-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 7,644,932 shares, $499,979 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 60,000 shares, $198,600 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: purchase of 7,644,932 shares @ $0.07 ($499,979) in Galera Therapeutics, Inc., filed 2025-01-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Galera Therapeutics, Inc. (GRTX) | Director, 10% owner | 4 | 1 leg · 7,644,932 sh · $499,979 | — | 8 |
| W&T OFFSHORE INC (WTI) | Director | 4 | — | 1 leg · 60,000 sh · $198,600 | 9 |
| Immix Biopharma, Inc. (IMMX) | Director | 2 | — | — | 3 |
Form 4 filings — CHANG NANCY T
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-05 | 4 | Galera Therapeutics, Inc. (GRTX) | Conversion (C): 661,309 · Disposition to issuer (D): 47,434 · Conversion (C): 661.31 (derivative) @ $0 · Disposition to issuer (D): 480 (derivative) | EDGAR |
| 2026-07-16 | 4 | W&T OFFSHORE INC (WTI) | Sale (S): 60,000 @ $3.31 | EDGAR |
| 2026-06-05 | 4 | W&T OFFSHORE INC (WTI) | Option exercise (M): 103,448 · Grant/award (A): 35,972 (derivative) @ $0 · Option exercise (M): 103,448 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | Immix Biopharma, Inc. (IMMX) | Grant/award (A): 6,250 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2026-04-09 | 4 | Galera Therapeutics, Inc. (GRTX) | Conversion (C): 1,180,611 · Conversion (C): 1,180.61 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | Immix Biopharma, Inc. (IMMX) | Grant/award (A): 39,643 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | W&T OFFSHORE INC (WTI) | Option exercise (M): 73,892 · Grant/award (A): 103,448 (derivative) @ $0 · Option exercise (M): 73,892 (derivative) @ $0 | EDGAR |
| 2025-02-26 | 4 | Galera Therapeutics, Inc. (GRTX) | Grant/award (A): 96,000 (derivative) @ $0 | EDGAR |
| 2025-01-02 | 4 | Galera Therapeutics, Inc. (GRTX) | Purchase (P): 7,644,932 @ $0.07 · Grant/award (A): 1,841.92 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | W&T OFFSHORE INC (WTI) | Option exercise (M): 38,760 · Grant/award (A): 73,892 (derivative) @ $0 · Option exercise (M): 38,760 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1135041 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →